Belgian researchers have countered an uncritical feature interview with animal rights activists who repeated factual inaccuracies about animal research and likened scientists to Nazis.
In response to the pieces in De Morgen and Humo (both in Flemish) the scientists refuted the claims that animal experiments are unreliable, that computer simulations and artificial intelligence are fully-fledged alternatives, that scientists just “do what they want” and that animal experiments are of no use (an attack on basic research). Full translation of Humo article
“Presenting researchers as Nazis is all too easy when we all reap the benefits of modern medicine,” said an article signed by Professor Rufin Vogels (KU Leuven), Professor Wim Van Duffel (KU Leuven and Harvard Medical School) and the animal research portal Infopunt Proefdieronderzoek (IPPO).
The response is as follows:
I and a number of colleagues are disappointed that for the second month in a row De Morgen forms a platform for the dissemination of incorrect information about animal testing. This time on the basis of an interview from Humo with three animal activists. Animal welfare is of course an important topic, but it is unfortunate that these three are given the opportunity to make statements about the context in which and the reasons for animal testing in Flanders, without making any comments. Continue reading →
Basic researchers into Alzheimer disease awarded major scientific prize
Today it was announced that the 2018 Brain Prize will be awarded to Bart De Strooper (VIB, KU Leuven and University College London), Michel Goedert (University of Cambridge), Christian Haass (DZNE, Ludwig-Maximilians-University) and John Hardy (UCL) for their groundbreaking research on the genetic and molecular basis of Alzheimer’s disease.
The four researchers will share the 1 million EUR prize awarded by the Lundbeck Foundation.
This year’s Brain Prize winners have made essential contributions, in basic research, to the genetic and molecular knowledge of Alzheimer’s, mapping new avenues for the diagnosis, treatment and possibly even prevention of this neurodegenerative disorder. Alzheimer’s disease is the most common cause of dementia, affecting approximately 30 million people worldwide. Continue reading →